Get started
Author

Pilar Varela Trastoy

Observed names: P Varela Trastoy, P. Varela Trastoy, P. Varela Trastoy,, P. Varela-Trastoy, P.V. Trastoy, Pilar Varela, Pilar Varela-Trastoy, Pilar Varela Trastoy
OpenAlex ID: A5031875933
Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 135
PDF
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 100
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry
2023 · María José García, Montserrat Rivero, et al. · Journal of Crohn s and Colitis · 23
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
2024 · María José Casanova, Berta Caballol, et al. · Digestive and Liver Disease · 19
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
2024 · Rocío Ferreiro‐Iglesias, Sol Porto Silva, et al. · Alimentary Pharmacology & Therapeutics · 11
Reingresos por pancreatitis aguda biliar edematosa en pacientes sin colecistectomía
2016 · Eva Barreiro Alonso, A. Mancebo-Mata, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 9
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
2021 · Alejandro Hernández Camba, Laura Ramos, et al. · Gastroenterología y Hepatología · 6
PDF
Efficacy and safety of intravenous ustekinumab maintenance therapy in Crohn�s disease
2023 · Benito Hermida Pérez, Alejo Mancebo Mata, et al. · Revista Española de Enfermedades Digestivas · 5
Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry
2026 · Manuel Barreiro‐de Acosta, Yamile Zabana, et al. · Alimentary Pharmacology & Therapeutics · 4
PDF
Post‐Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU
2026 · J. L. Rueda García, C. Suárez Ferrer, et al. · Alimentary Pharmacology & Therapeutics · 4
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
2022 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 4
A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn�s disease
2019 · Eduardo López Fernández, María Curieses Luengo, et al. · Revista Española de Enfermedades Digestivas · 4
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study
2024 · Patricia Sanz Segura, Fernando Gomollón, et al. · Digestive and Liver Disease · 3
PDF
Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry
2026 · Montserrat Guasch, Margalida Calafat, et al. · Inflammatory Bowel Diseases · 1
P0692 Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU
2025 · M Chaparro, S Hermida, et al. · Journal of Crohn s and Colitis · 1
PDF
P0609 Real-world short and long-term effectiveness of risankizumab in refractory Crohn’s disease: RISANCROHN study from the ENEIDA Registry
2025 · M Barreiro-de Acosta, L Nieto-Garcia, et al. · Journal of Crohn s and Colitis · 1
PDF
Factores Predictores Del Uso De Tratamientos Biológicos O Pequeñas Moléculas, Cirugías Y Hospitalizaciones En Una Cohorte De Pacientes Recién Diagnosticados De Eii: Resultados a Largo Plazo Del Estudio Epidemibd De Geteccu
2025 · Ana Garre Vázquez, Andrea Núñez Ortiz, et al. · Gastroenterología y Hepatología · 1
P1170 Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU
2024 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
PDF
Intestinal Resection in Crohn's Disease. Impact of Timing of Surgery on Postoperative Complications and Recurrence. Retrospective Cohort Study
2024 · César Gómez Díez, Pilar Varela Trastoy, et al. · Revista Española de Enfermedades Digestivas · 1
Analysis of the effectiveness and safety of maintenance treatment with intravenous ustekinumab in inflammatory bowel disease
2024 · Rubén Pampín Sánchez, Alba Gonzalo González, et al. · Revista Española de Enfermedades Digestivas · 1
P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
2022 · R Ferreiro Iglesias, M S Porto Silva, et al. · Journal of Crohn s and Colitis · 1
PDF
OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study
2021 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
PDF
Preliminary Experience in Maintenance Treatment With Intravenous Ustekinumab as a Rescue for Loss of Response to Subcutaneous Doses
2020 · Isabel Pérez Valle, Pilar Varela Trastoy, et al. · Revista Española de Enfermedades Digestivas · 1
Hypertriglyceridemia-induced acute pancreatitis: An unusual cause of abdominal pain in pregnancy
2019 · N. Pérez-Martínez, A. Mancebo-Mata, et al. · Revista de Gastroenterología de México (English Edition) · 1
PDF
Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis
2017 · Marta Izquierdo Romero, Pilar Varela Trastoy, et al. · Revista Española de Enfermedades Digestivas · 1
Works count: 57
Citation count: 339
H-index: 6
I10-index: 5
Year
Topic
Type